Viagra vs Hezkue for Erectile Dysfunction
What You Need to Know Before You Apply
What is the purpose of this trial?
The objective of this phase 1, open-label, single-center, two-way crossover trial is to evaluate the pharmacokinetics (PK), safety, and tolerability of 100 mg ASP-001 oral liquid suspension versus 100 mg Viagra (sildenafil citrate) tablets in fasted, healthy male volunteers
Are You a Good Fit for This Trial?
This trial is for healthy, fasted male participants who want to help compare the effects of two erectile dysfunction treatments: Viagra and a new drug called Hezkue (ASP-001).Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment Period I
Participants receive either 100 mg of ASP-001 or 100 mg of Viagra
Washout
A washout period between treatment periods
Treatment Period II
Participants receive the alternate treatment (100 mg of ASP-001 or 100 mg of Viagra)
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- ASP-001
- Viagra
Find a Clinic Near You
Who Is Running the Clinical Trial?
Aspargo Labs, Inc
Lead Sponsor